Business
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and reported financial results for the first quarter ended March 31, 2026.
About this update from Pavmed Inc.
[{"type":"text","content":"Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission","length":125,"tagName":"p","attribs":{}},{"type":"text","content":"Lucid Diagnostics continued building commercial momentum and strengthened its balance sheet ahead of key upcoming reimbursement milestones","length":138,"tagName":"p","attribs":{}},{"type":"text","content":"PAVmed advanced its relaunched medical device portfolio; evaluation of additional acquisition opportunities ongoing","length":115,"tagName":"p","attribs":{}},{"type":"text","content":"Conference call and webcast to be held today, May 15, at 8:30 AM EDT","length":68,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, May 15, 2026 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and reported financial results for the first quarter ended March 31, 2026.","length":504,"tagName":"p"},{"type":"image","alt":"PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. (PRNewsfoto/PAVmed Inc.)","displaySize":"","headline":null,"caption":"PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. (PRNewsfoto/PAVmed Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":81,"url":"https://media.zenfs.com/en/prnewswire.com/b33818e0ad32f6b512ca93166f23ff80"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kkK20uZJNED_IOvxDV4XCA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE0Mw--/https://media.zenfs.com/en/prnewswire.com/b33818e0ad32f6b512ca93166f23ff80","width":400,"height":81},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/LmfqZTKC6ziLmPQdGadD_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTEzMA--/https://media.zenfs.com/en/prnewswire.com/b33818e0ad32f6b512ca93166f23ff80","width":400,"height":81}},"href":"https://mma.prnewswire.com/media/2011714/PAVmed_updated_Logo.html","hrefExternal":...